JNCI Journal of the National Cancer Institute

REVIEWS

JC Reed

Promise and problems of Bcl-2 antisense therapy
J. Natl. Cancer Inst. 1997 89: 988; doi:10.1093/jnci/89.14.988 [PDF]  

DF Hayes

Ductal carcinoma in situ of the breast: a new model
J. Natl. Cancer Inst. 1997 89: 991; doi:10.1093/jnci/89.14.991 [PDF]  

WL Stone and AM Papas

Tocopherols and the etiology of colon cancer
J. Natl. Cancer Inst. 1997 89: 1006; doi:10.1093/jnci/89.14.1006 [Abstract] [PDF]  

National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Development Panel
J. Natl. Cancer Inst. 1997 89: 1015; doi:10.1093/jnci/89.14.1015 [Abstract] [PDF]  

RB Hayes, SN Yin, M Dosemeci, GL Li, S Wacholder, LB Travis, CY Li, N Rothman, RN Hoover, and MS Linet

Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine--National Cancer Institute Benzene Study Group
J. Natl. Cancer Inst. 1997 89: 1065; doi:10.1093/jnci/89.14.1065 [Abstract] [PDF]  

NEWS

C McNeil

Are changes in end-of-life cancer care coming? IOM, ASCO tackle issues
J. Natl. Cancer Inst. 1997 89: 994.  

H Heimer

Virtual reality researchers seek to minimize invasive diagnostic procedures
J. Natl. Cancer Inst. 1997 89: 997.  

L Daley

Keying educational messages to high-risk populations
J. Natl. Cancer Inst. 1997 89: 998.  

B Kuska

Kiwi conundrum: Screening for prostate cancer
J. Natl. Cancer Inst. 1997 89: 1000.  

KJ Smeltz

Common ground found: "Overall cancer mortality rates are falling"
J. Natl. Cancer Inst. 1997 89: 1001.  

ARTICLES

DL Sackett

A science for the art of consensus
J. Natl. Cancer Inst. 1997 89: 1003; doi:10.1093/jnci/89.14.1003 [PDF]  

A Ziegler, GH Luedke, D Fabbro, KH Altmann, RA Stahel, and U Zangemeister-Wittke

Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence
J. Natl. Cancer Inst. 1997 89: 1027; doi:10.1093/jnci/89.14.1027 [Abstract] [PDF]  

C Gomez-Manzano, J Fueyo, AP Kyritsis, TJ McDonnell, PA Steck, VA Levin, and WK Yung

Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis
J. Natl. Cancer Inst. 1997 89: 1036; doi:10.1093/jnci/89.14.1036 [Abstract] [PDF]  

SB Fox, RD Leek, J Bliss, JL Mansi, B Gusterson, KC Gatter, and AL Harris

Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients
J. Natl. Cancer Inst. 1997 89: 1044; doi:10.1093/jnci/89.14.1044 [Abstract] [PDF]  

F Cavallo, P Signorelli, M Giovarelli, P Musiani, A Modesti, MJ Brunda, MP Colombo, and G Forni

Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12
J. Natl. Cancer Inst. 1997 89: 1049; doi:10.1093/jnci/89.14.1049 [Abstract] [PDF]  

PA Holland, WF Knox, CS Potten, A Howell, E Anderson, AD Baildam, and NJ Bundred

Assessment of hormone dependence of comedo ductal carcinoma in situ of the breast
J. Natl. Cancer Inst. 1997 89: 1059; doi:10.1093/jnci/89.14.1059 [Abstract] [PDF]  

JG Gurney, JM Pogoda, EA Holly, SS Hecht, and S Preston-Martin

Aspartame consumption in relation to childhood brain tumor risk: results from a case-control study [published erratum appears in J Natl Cancer Inst 1997 Oct 1;89(19):1460]
J. Natl. Cancer Inst. 1997 89: 1072; doi:10.1093/jnci/89.14.1072 [PDF]  

CORRESPONDENCE

EP Diamandis

Clinical application of ultrasensitive prostate-specific antigen assays
J. Natl. Cancer Inst. 1997 89: 1077; doi:10.1093/jnci/89.14.1077 [PDF]  

FH Schilling

Re: Neuroblastoma screening test may do more harm than good
J. Natl. Cancer Inst. 1997 89: 1078; doi:10.1093/jnci/89.14.1078 [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.